# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 14: Amendment of regulation 33 (notification of suspected unexpected serious adverse reactions)


(1) Regulation 33 is amended as follows.
(2) Omit paragraph (1)(b)(ii).
(3) Omit paragraph (3)(b).
(4) Omit paragraph (4).
(5) Omit paragraph (6)(b), and the “and” immediately preceding it.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/14 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-14
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.